Evidence map›Paper›PMID 24090823›Full record

ArticleNeuroscience and biobehavioral reviews2013

Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models.

Holly Moore, Mark A Geyer, Cameron S Carter, Deanna M Barch

Abstract readEditorial
In one paragraph

Article in Neuroscience and biobehavioral reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  18. Article
  19. Chemogenetic Inactivation of Dorsal Anterior Cingulate Cortex Neurons Disrupts Attentional Behavior in Mouse.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Holly MooreDepartment of Psychiatry, Columbia University, New York, NY, USA; Department of Integrative Neuroscience, New York State Psychiatric Institute, New York, NY, USA. Electronic address: hm2035@columbia.edu.
Mark A Geyer
Cameron S Carter
Deanna M Barch

Funding

The Regulation of MGE Proliferation and Cortical Interneuron Fate DeterminationP01NS048120 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI ANDERSON, STEWART A · 2006 to 2015
$12.9M
Dopamine Dysfunction in SchizophreniaP50MH086404 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ABI-DARGHAM, ANISSA · 2010 to 2014
$9.4M
Brain-Based Treatment--Impaired Cognition SchizophreniaR13MH078710 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARTER, CAMERON S. · 2006 to 2010
$589k
NIMH NIH HHS 1R13MH078710NIMH NIH HHS P50 MH086404NIMH NIH HHS R13 MH078710NINDS NIH HHS P01 NS048120
6 · The paper itself

Abstract

Over the past two decades, the awareness of the disabling and treatment-refractory effects of impaired cognition in schizophrenia has increased dramatically. In response to this still unmet need in the treatment of schizophrenia, the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) initiative was developed. The goal of CNTRICS is to harness cognitive neuroscience to develop a brain-based set of tools for measuring cognition in schizophrenia and to test new treatments. CNTRICS meetings focused on development of tasks with cognitive construct validity for use in both human and animal model studies. This special issue presents papers discussing the cognitive testing paradigms selected by CNTRICS for animal model systems. These paradigms are designed to measure cognitive constructs within the domains of perception, attention, executive function, working memory, object/relational long-term memory, and social/affective processes.

Indexed as

NeurosciencesAnimalsCognition DisordersDisease Models, AnimalHumansSchizophreniaBehaviorCNTRICSCognitive Neuroscience Treatment Research to Improve Cognition in SchizophreniaMouseNon-human primatePsychopharmacologyPsychosisRat

Identifiers

PMID24090823
PMCPMC3965347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.